Category: Breaking News
-
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency
Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the…
-
STAT+: CMS halts enrollment in Elevance’s Medicare Advantage plans, citing years of misconduct
STAT+: CMS halts enrollment in Elevance’s Medicare Advantage plans, citing years of misconduct Elevance Health will no longer be able to enroll people into its Medicare Advantage plans starting March 31, according to a new, harshly worded suspension notice from the Centers for Medicare and Medicaid Services. CMS is imposing the punishment after Elevance failed…
-
Ralph Abraham, No. 2 official at CDC, abruptly steps down
Ralph Abraham, No. 2 official at CDC, abruptly steps down The drama and chaos surrounding the leadership of the Centers for Disease Control and Prevention have taken another twist, with the announcement Monday that the agency’s No. 2 official, Ralph Abraham, has resigned. A statement posted to the CDC’s website said Abraham, a former Louisiana…
-
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition OhioHealth is the latest nonprofit health system to find itself in the government’s crosshairs for allegedly using its market power to suppress competition and drive up costs. The Department of Justice and Ohio’s attorney general filed a civil antitrust lawsuit against…
-
STAT+: FDA taps AI executive to lead digital health center
STAT+: FDA taps AI executive to lead digital health center The Food and Drug Administration has tapped a former executive from a health artificial intelligence company to lead its digital health center. Rick Abramson, formerly a chief medical officer at a subsidiary of Harrison.ai, which develops AI products to interpret radiological images, is the new…
-
STAT+: NIH Director Bhattacharya to lead CDC after O’Neill’s exit
STAT+: NIH Director Bhattacharya to lead CDC after O’Neill’s exit WASHINGTON — National Institutes of Health Director Jay Bhattacharya will take on leadership of the Centers for Disease Control and Prevention on an acting basis, an administration official not authorized to speak publicly confirmed to STAT. Bhattacharya is taking the role after the previous acting…
-
STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods
STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods Health secretary Robert F. Kennedy Jr. fired the starting gun in a challenge to the food industry on Sunday, announcing on CBS’ “60 Minutes” that he plans to act on a plan outlined by former Food and Drug Administration chief David Kessler to overhaul…
-
STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a therapy developed by Disc Medicine to treat the rare blood disorder porphyria, which makes patients extremely sensitive to sunlight. It’s the first experimental drug to go through FDA Commissioner…
-
Major shakeup underway at HHS as White House braces for midterms
Major shakeup underway at HHS as White House braces for midterms WASHINGTON — Two top health officials are leaving their jobs amid a shakeup at the Department of Health and Human Services aimed at refocusing HHS on politically popular aspects of health secretary Robert F. Kennedy Jr.’s agenda in advance of the midterm elections. Deputy…
-
STAT+: FDA refuses to review Moderna’s influenza vaccine
STAT+: FDA refuses to review Moderna’s influenza vaccine The Food and Drug Administration refused to review Moderna’s application for a new influenza vaccine, the company said Tuesday, a surprise decision that could raise concerns about the agency’s posture toward drug companies and the Trump administration’s policies on vaccines. Moderna, revealing the rejection, took the unusual…
-
STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access The Federal Trade Commission said Wednesday that it had settled a lawsuit against Express Scripts, one of the largest pharmacy benefit managers in the U.S., over allegations that the company artificially inflated the price of insulin and impeded access to…
-
STAT+: UnitedHealth limps into 2026 with a smaller business and fresh challenges
STAT+: UnitedHealth limps into 2026 with a smaller business and fresh challenges UnitedHealth Group enters 2026 limping financially after one of the most turbulent years in the company’s history, but executives at the health insurance and services giant made it clear they will cut their way to higher profits. On Tuesday, UnitedHealth said revenue would…
-
STAT+: Trump releases health care plan amid pressure over affordability
STAT+: Trump releases health care plan amid pressure over affordability WASHINGTON — President Trump on Thursday released a hodgepodge of health care policies that would create new price-control power over pharmaceutical companies, but that otherwise wouldn’t fundamentally overhaul America’s existing system, as he faces mounting pressure to address the cost of insurance and care. The…
-
Trump administration cuts up to $1.9 billion from mental health and addiction treatment programs
Trump administration cuts up to $1.9 billion from mental health and addiction treatment programs The federal agency that oversees mental health and addiction treatment on Tuesday made major cuts to programs across the behavioral health field, according to eight sources with knowledge of the decisions. While the exact funding cuts enacted by the Substance Abuse…
-
STAT+: HHS dismisses member of vaccine injury advisory panel
STAT+: HHS dismisses member of vaccine injury advisory panel WASHINGTON — At least one member of a committee that advises the federal government on its vaccine injury compensation program has had her term prematurely ended, potentially foreshadowing further changes to the federal apparatus that reviews vaccine injuries and compensates patients. Veronica McNally, an attorney who…
-
STAT+: House passes ACA subsidy extension as bipartisan negotiations heat up in Senate
STAT+: House passes ACA subsidy extension as bipartisan negotiations heat up in Senate WASHINGTON — The House voted 230 to 196 to pass a three-year extension of enhanced Affordable Care Act premium subsidies, with 17 Republicans joining all Democrats in favor. Five Republicans did not vote. That the House considered the matter at all shows…
-
Dietary guidelines declare war on processed foods and sugar, encourage more protein and dairy
Dietary guidelines declare war on processed foods and sugar, encourage more protein and dairy The Trump administration on Wednesday issued a long-promised revamp of national dietary guidelines, urging Americans to eat more protein and less added sugar and, for the first time, discouraging consumption of highly processed foods. The guidelines, despite widespread expectations, do not…
-
Federal health officials slash recommended childhood vaccinations under Trump’s directive
Federal health officials slash recommended childhood vaccinations under Trump’s directive WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response to an order from President Trump, the most significant reshaping of the vaccine schedule since Trump took office and empowered health secretary Robert F. Kennedy Jr., a longtime critic…
-
Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI
Trump administration agrees to reconsider frozen and denied NIH grant submissions related to DEI The Trump administration has reached an agreement to reevaluate research projects left in bureaucratic limbo while a lawsuit over the termination of thousands of grants from the National Institutes of Health moves through the courts. The decision caps off a tumultuous…
-
FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access
FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access The Food and Drug Administration on Monday approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to be cleared by regulators for obesity and possibly allowing many more Americans to get access to a highly…
-
In major effort to end gender-affirming care, Trump administration takes aim at hospitals
In major effort to end gender-affirming care, Trump administration takes aim at hospitals The Trump administration is making its most forceful attempt yet at restricting gender-affirming care for transgender youth in the U.S. The Centers for Medicare and Medicaid Services proposed on Thursday two rules to withhold federal funds in connection with gender-affirming care for…
-
STAT+: More drugmakers set to sign pricing deals with Trump on Friday
STAT+: More drugmakers set to sign pricing deals with Trump on Friday WASHINGTON — Several drugmakers are expected to sign pricing agreements with the Trump administration on Friday, according to four people familiar with the plans, who were not authorized to speak publicly. The agreements would be the latest in a series of deals in…
-
FDA approves first new kind of drug to target gonorrhea in decades
FDA approves first new kind of drug to target gonorrhea in decades A new kind of oral antibiotic to treat gonorrhea has secured Food and Drug Administration approval, the second time in two days that a new drug for the common sexually transmitted infection has come through licensure. Neisseria gonorrhoeae, the bacterium that causes gonorrhea,…
-
STAT+: ACA premium spike looms as Senate votes fail, House bill faces long odds
STAT+: ACA premium spike looms as Senate votes fail, House bill faces long odds WASHINGTON — Senators on Thursday failed to pass legislation aimed at controlling health insurance costs for people with Affordable Care Act plans after dueling partisan bills were voted down mostly along party lines. Four Republicans voted for the Democratic bill, while…
-
STAT+: New data from Gilead, Arcellx multiple myeloma CAR-T suggest benefit over rival treatment
STAT+: New data from Gilead, Arcellx multiple myeloma CAR-T suggest benefit over rival treatment ORLANDO, Fla. — With sales of its existing blood cancer CAR-T therapies weakening, Gilead Sciences needs anito-cel, its next CAR-T therapy for multiple myeloma — to succeed more than ever. On Saturday at the annual meeting of the American Society of…
-
CDC panel recommends delaying birth dose of hepatitis B vaccine
CDC panel recommends delaying birth dose of hepatitis B vaccine A panel that advises on U.S. vaccine policy voted on Friday to recommend a delay in when most babies begin to be vaccinated against hepatitis B, overturning a 30-year-old policy that has contributed to a massive decline in cases of the virus. The Advisory Committee…
-
STAT+: FDA removes longtime over-the-counter drugs regulator from her position
STAT+: FDA removes longtime over-the-counter drugs regulator from her position WASHINGTON — The Food and Drug Administration removed the longtime director of the office of over-the-counter drugs from her position on Wednesday, six agency sources told STAT. Theresa Michele, director of the Office of Nonprescription Drugs, has worked at the FDA since at least 2015.…
-
STAT+: Top drug regulator Richard Pazdur set to leave the FDA
STAT+: Top drug regulator Richard Pazdur set to leave the FDA WASHINGTON — Top drug regulator Richard Pazdur has filed papers to retire from the Food and Drug Administration at the end of this month, adding to the turmoil atop the agency. Pazdur informed leaders at the FDA’s drug center of his intention to leave…
-
STAT+: Richard Pazdur, longtime cancer regulator, named drug center director at FDA
STAT+: Richard Pazdur, longtime cancer regulator, named drug center director at FDA WASHINGTON — The Food and Drug Administration on Tuesday named Richard Pazdur, its longtime overseer of cancer therapies, as its top drug regulator. Pazdur replaces former Center for Drug Evaluation and Research Director George Tidmarsh, who exited the agency earlier this month amid…
-
Canada loses measles elimination status — as does the entire Americas region
Canada loses measles elimination status — as does the entire Americas region Canada has formally lost its measles elimination status, the country’s public health agency announced Monday, meaning all of the Americas have lost that status as well. The decision, which was widely expected, comes after a meeting last week where an expert committee of the…
-
STAT+: FDA announces next round of priority review vouchers
STAT+: FDA announces next round of priority review vouchers WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to speedier reviews of drug candidates aligned with U.S. priorities. The announcement came as the Trump administration unveiled agreements with Eli Lilly and…
-
STAT+: Trump administration nears deals for cheaper weight loss drugs with Novo Nordisk, Eli Lilly
STAT+: Trump administration nears deals for cheaper weight loss drugs with Novo Nordisk, Eli Lilly WASHINGTON — The Trump administration is nearing deals with Eli Lilly and Novo Nordisk to lower the prices of their weight loss drugs and expand access to them, people familiar with the talks told STAT. The companies have been close to…
-
STAT+: FDA’s top drug regulator placed on leave amid investigation
STAT+: FDA’s top drug regulator placed on leave amid investigation WASHINGTON — George Tidmarsh, the Food and Drug Administration’s top regulator of drugs, has been placed on administrative leave after being accused of using his regulatory authority to inflict financial harm on a former business associate, STAT has learned. FDA Commissioner Marty Makary relieved Tidmarsh of…
-
STAT+: Pfizer sues Novo Nordisk, Metsera for breach of merger agreement
STAT+: Pfizer sues Novo Nordisk, Metsera for breach of merger agreement Pfizer said Friday it’s suing Novo Nordisk and obesity biotech Metsera, a day after Novo set off a bidding war against Pfizer to acquire Metsera. A month ago, Pfizer said that it would acquire Metsera for $4.9 billion. But Novo on Thursday launched a…
-
STAT+: FDA moves to ease path for biosimilars as Trump seeks to cut drug costs
STAT+: FDA moves to ease path for biosimilars as Trump seeks to cut drug costs WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs to market with the aim of making medicine more affordable and accessible for patients. The framework will shorten the path…
-
STAT+: Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer
STAT+: Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer Eli Lilly announced a partnership with chipmaker NVIDIA on Tuesday to build what it claims will be the “most powerful supercomputer owned and operated by a pharmaceutical company.” Lilly’s technology investment is meant to help the drugmaker tap into the potential of artificial…
-
STAT+: Moderna says key study of its CMV vaccine, expected to be its next big win, failed
STAT+: Moderna says key study of its CMV vaccine, expected to be its next big win, failed Moderna said Wednesday afternoon that its experimental vaccine for cytomegalovirus, a cause of disability in newborns, failed in a Phase 3 trial, a significant setback for a company already facing pressure from Wall Street and the federal government.…
-
STAT+: Enhertu pushes into early breast cancer, as antibody-drug conjugates move up the line
STAT+: Enhertu pushes into early breast cancer, as antibody-drug conjugates move up the line BERLIN — Enhertu has become a staple treatment in advanced breast cancer, but new data presented Saturday at the European Society for Medical Oncology’s annual conference show the drug can have powerful benefits for patients when given earlier in the disease,…
-
STAT+: Medicare payments to doctors paused as government shutdown drags on
STAT+: Medicare payments to doctors paused as government shutdown drags on The Centers for Medicare and Medicaid Services is pausing Medicare payments to doctors, as negotiations tied to the government shutdown drag on. CMS announced the pause in a notice on its website but didn’t say when it would end. It’s happening because Congress needs…
-
STAT+: AstraZeneca strikes drug pricing deal with Trump
STAT+: AstraZeneca strikes drug pricing deal with Trump WASHINGTON — President Trump on Friday said he struck a drug pricing deal with AstraZeneca aimed at fulfilling his plan to bring U.S. drug prices in line with what other countries pay, the second agreement after Pfizer’s last week. Similar to Pfizer’s deal, the British pharma company…
-
STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown WASHINGTON — Federal health employees on Friday were being fired as the White House followed through on its threat to terminate federal employees en masse as the second week of the government shutdown drags to a close. Between 1,100…
-
STAT+: Peter Marks, FDA vaccine regulator ousted by RFK Jr., joins Eli Lilly
STAT+: Peter Marks, FDA vaccine regulator ousted by RFK Jr., joins Eli Lilly WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly to oversee molecule discovery and infectious diseases — a move that quickly drew criticism for the revolving door between the agency and industry. Marks confirmed…
-
Trump strikes deal with Pfizer aimed at lowering prescription drug prices
Trump strikes deal with Pfizer aimed at lowering prescription drug prices WASHINGTON — President Trump announced on Tuesday that Pfizer has agreed to offer lower prices on its drugs to the Medicaid program and directly to patients, the first in what he said would be a series of deals intended to secure cheaper prescription medicines…
-
STAT+: FDA brings back GSK’s leucovorin drug that RFK Jr. touted as autism treatment
STAT+: FDA brings back GSK’s leucovorin drug that RFK Jr. touted as autism treatment In a highly unusual move, the Food and Drug Administration reapproved a drug on Monday that stopped being sold more than 25 years ago, part of a push from the Trump administration to identify the causes of and potential treatments for…
-
Citing possible link to autism, Trump urges limiting use of Tylenol during pregnancy
Citing possible link to autism, Trump urges limiting use of Tylenol during pregnancy President Trump announced on Monday that his administration has concluded that some cases of autism may be linked to pregnant women’s use of acetaminophen, the active ingredient in Tylenol, and said the medication should be used sparingly and only if absolutely needed…
-
Federal vaccine panel remade by RFK Jr. votes to maintain insurance coverage for Covid shots
Federal vaccine panel remade by RFK Jr. votes to maintain insurance coverage for Covid shots WASHINGTON — A government advisory committee voted unanimously Friday to recommend that individuals 6 months and older should discuss the risks and benefits of Covid-19 vaccines with their health care providers before deciding whether to get vaccinated. The decision falls…
-
Cassidy calls for meeting of CDC vaccine advisers to be postponed following agency shakeup
Cassidy calls for meeting of CDC vaccine advisers to be postponed following agency shakeup WASHINGTON — A top Senate leader is calling for next month’s meeting of a federal advisory panel on vaccines to be postponed in the wake of a mass exodus of leaders at the Centers for Disease Control and Prevention. “Serious allegations…
-
FDA issues narrower approvals for Covid boosters, revokes emergency authorizations
FDA issues narrower approvals for Covid boosters, revokes emergency authorizations WASHINGTON — The Food and Drug Administration on Wednesday approved updated Covid boosters, but removed emergency use authorizations for the vaccines, in a set of moves that could make the shots more difficult to obtain for children under 5, in particular. The moves were announced…
-
CDC Director Susan Monarez is ousted as senior leaders exit agency
CDC Director Susan Monarez is ousted as senior leaders exit agency WASHINGTON — Susan Monarez, the first Senate-confirmed director of the Centers for Disease Control and Prevention, has been ousted after just a month on the job — part of a series of high-ranking exits at the CDC. The Trump administration confirmed her departure but provided…
-
CDC attacker likely attempted to enter campus days before shooting
CDC attacker likely attempted to enter campus days before shooting WASHINGTON — The man who attacked the Centers for Disease Control and Prevention probably tried to enter the agency’s Atlanta campus days before the shooting, investigators believe. The shooter, identified by authorities as Patrick Joseph White, appears to have been captured in security camera footage…
-
STAT+: Elevance loses lawsuit over Medicare Advantage quality ratings
STAT+: Elevance loses lawsuit over Medicare Advantage quality ratings A federal judge in Texas struck down Elevance Health’s lawsuit that argued the government unfairly lowered its Medicare Advantage quality ratings — a decision that could cost Elevance $375 million in bonus revenue. U.S. District Judge Mark T. Pittman, appointed by President Trump in 2019, chastised…
-
STAT+: DOJ and UnitedHealth reach settlement on $3.3 billion Amedisys deal
STAT+: DOJ and UnitedHealth reach settlement on $3.3 billion Amedisys deal The Department of Justice and state officials have reached a proposed settlement agreement with UnitedHealth Group and Amedisys that would allow the companies to complete their $3.3 billion combination so long as they agree to sell 164 home health and hospice locations across 19…
-
Trump administration violated impoundment law by canceling NIH grants, slowing new awards, GAO finds
Trump administration violated impoundment law by canceling NIH grants, slowing new awards, GAO finds In a scathing report issued Tuesday, the Government Accountability Office found that the Trump administration, by abruptly canceling National Institutes of Health grants, had violated a 1974 law blocking presidents from withholding funding Congress has approved. The independent congressional watchdog said…
-
Gates Foundation pledges $2.5 billion to women’s health initiatives
Gates Foundation pledges $2.5 billion to women’s health initiatives The Gates Foundation said Monday that it would commit $2.5 billion through 2030 to support dozens of different approaches for improving women’s health, from new medicines to prevent maternal mortality to vaccines to curb infections that disproportionately affect women. The figure represents an increase of about…
-
STAT+: Senators leave RFK Jr.’s MAHA agency out of 2026 budget in apparent snub
STAT+: Senators leave RFK Jr.’s MAHA agency out of 2026 budget in apparent snub WASHINGTON — Senate appropriators seemingly snubbed an effort by health secretary Robert F. Kennedy Jr. to reorganize certain primary care and chronic health programs into a new agency known as the Administration for a Healthy America. Instead, a fiscal 2026 budget…
-
Trump escalates demands that pharma companies lower their drug prices
Trump escalates demands that pharma companies lower their drug prices President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries pay, sending letters to 17 major drug companies Thursday that called on them to take actions by Sept. 29. He specifically asked the firms to: provide their…
-
STAT+: Preventive care panel could be restructured ‘imminently’ as RFK Jr. vets new members
STAT+: Preventive care panel could be restructured ‘imminently’ as RFK Jr. vets new members WASHINGTON — Health secretary Robert F. Kennedy Jr. could “imminently” overhaul a key federal advisory panel that recommends which preventive services insurers must pay for, according to a person familiar with the plans. The person said that federal health officials are…
-
STAT+: FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt
STAT+: FDA permits use of Sarepta Therapeutics’ Duchenne therapy in younger patients after short-lived halt In a sharp reversal, the Food and Drug Administration on Monday said it was clearing the way for Sarepta Therapeutics to resume shipments of its gene therapy for Duchenne muscular dystrophy to some patients. The therapy, called Elevidys, will once…
-
STAT+: 10 million expected to lose health insurance under Trump’s tax cut law, CBO says
STAT+: 10 million expected to lose health insurance under Trump’s tax cut law, CBO says WASHINGTON — President Trump’s major domestic policy law will result in nearly 10 million more people going without health insurance by 2034, according to the Congressional Budget Office’s estimate on the final law. The law, which included significant cuts in…
-
STAT+: Sarepta Therapeutics crisis is huge blow to Duchenne families, company
STAT+: Sarepta Therapeutics crisis is huge blow to Duchenne families, company Sarepta Therapeutics confronted one of the most serious crises in its history on Friday, as the Food and Drug Administration prepared to ask the company to halt all shipments of its gene therapy for Duchenne muscular dystrophy — a treatment that had been a…
-
STAT+: Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
STAT+: Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move Sarepta Therapeutics laid off more than one-third of its workforce, or approximately 500 employees, the company announced Wednesday — a drastic cost-cutting move following the deaths of two teenagers that forced the company to restrict usage of its gene therapy for Duchenne muscular…
-
STAT+: Kennedy abruptly cancels preventive care committee meeting
STAT+: Kennedy abruptly cancels preventive care committee meeting WASHINGTON — Health secretary Robert F. Kennedy Jr. has abruptly canceled a meeting of a key expert panel that evaluates the nation’s preventive care recommendations, according to an email viewed by STAT. The email did not cite a reason. The cancellation of the Thursday meeting of the U.S.…
-
Leading medical groups sue Kennedy over changed Covid-19 vaccine recommendations
Leading medical groups sue Kennedy over changed Covid-19 vaccine recommendations WASHINGTON — Six major medical groups, and a pregnant physician, are suing health secretary Robert F. Kennedy Jr. over changes he made to Covid-19 vaccine recommendations that they say were unlawful and undermine public trust in health care. The suit argues that a May 19 directive…
-
Senate passes Trump’s tax-cut bill that would slash Medicaid spending
Senate passes Trump’s tax-cut bill that would slash Medicaid spending WASHINGTON — The Senate passed a $4.5 trillion tax-cut bill after last-minute changes to its health care provisions, as Republicans scrambled to get their party on board. The legislation that passed on Tuesday includes major federal funding cuts to Medicaid that were opposed by hospitals and…
-
STAT+: Centene’s stock plummets as health insurance giant scraps 2025 financial outlook
STAT+: Centene’s stock plummets as health insurance giant scraps 2025 financial outlook Centene has withdrawn its financial guidance for the rest of the year after receiving data that showed its health insurance members in Affordable Care Act plans are getting a lot more care than the company had anticipated. The company is also seeing a…
-
CDC advisory panel, selected by RFK Jr., recommends thimerosal be dropped from flu vaccines
CDC advisory panel, selected by RFK Jr., recommends thimerosal be dropped from flu vaccines A federal vaccine advisory panel, which health secretary Robert F. Kennedy Jr. recently stacked with handpicked members, recommended on Thursday that Americans should not receive flu vaccines containing the preservative thimerosal. The votes — there were three related to the topic…
-
STAT+: Top gene therapy regulator forced out at FDA
STAT+: Top gene therapy regulator forced out at FDA Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her deputy Rachael Anatol have been placed on administrative leave and escorted out of the agency, according to a recording of a meeting obtained by STAT. Verdun…
-
STAT+: Senate GOP proposes to rein in states’ tools to boost Medicaid funding
STAT+: Senate GOP proposes to rein in states’ tools to boost Medicaid funding WASHINGTON — To help pay for President Trump’s tax cuts, the Senate is clamping down on tactics that states use to boost federal Medicaid funding, according to legislation released by the Senate Finance Committee on Monday. The text includes harsher restrictions on…
-
RFK Jr. names new members of CDC’s vaccine advisory panel
RFK Jr. names new members of CDC’s vaccine advisory panel WASHINGTON — Health secretary Robert F. Kennedy Jr. on Wednesday unveiled the names of the eight new members who will sit on the panel of experts that advises the Centers for Disease Control and Prevention on vaccine policy, and said they would review the current…
-
Health secretary RFK Jr. abruptly fires CDC vaccine advisory panel
Health secretary RFK Jr. abruptly fires CDC vaccine advisory panel Health secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the Centers for Disease Control and Prevention on immunizations, saying the action is needed to restore faith in vaccines. “A clean sweep is needed to re-establish public…
-
10.9 million people would lose health insurance under Trump’s tax cut bill, CBO projects
10.9 million people would lose health insurance under Trump’s tax cut bill, CBO projects WASHINGTON — House Republicans’ tax bill would lead to nearly 11 million people losing health insurance, providing a key source of savings to help finance President Trump’s tax cuts, according to projections that nonpartisan congressional scorekeepers published Wednesday. Another 5.1 million…
-
STAT+: UnitedHealth conducting ‘comprehensive review’ of Medicare practices that are facing federal scrutiny, new CEO says
STAT+: UnitedHealth conducting ‘comprehensive review’ of Medicare practices that are facing federal scrutiny, new CEO says UnitedHealth Group’s new CEO told investors that the company is reevaluating how it tallies Medicare Advantage patients’ diagnoses for reimbursement purposes, an issue currently under investigation by the Justice Department. Stephen Hemsley’s remarks during the company’s annual shareholder meeting…
-
STAT+: HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics
STAT+: HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics This story will be updated The Department of Health and Human Services has notified Moderna that it is canceling a nearly $600 million contract with the company to develop, test, and license vaccines for flu strains that could trigger future pandemics, including…
-
RFK Jr. rolls back Covid vaccine recommendations for healthy children, pregnant people
RFK Jr. rolls back Covid vaccine recommendations for healthy children, pregnant people Health secretary Robert F. Kennedy Jr. announced Tuesday that he has unilaterally struck the recommendation that healthy children and healthy pregnant people get Covid-19 booster shots — a move that experts say is unprecedented. Kennedy made the announcement on the social media site X,…
-
STAT+: Trump, building on Biden policy, to speed up audits of Medicare Advantage insurers
STAT+: Trump, building on Biden policy, to speed up audits of Medicare Advantage insurers President Trump’s federal Medicare agency will expedite audits of Medicare Advantage insurers, a move that could claw back nearly $500 million a year for taxpayers, according to previous federal estimates. However, the audits remain mired in a two-year-old lawsuit initiated by…
-
Former President Biden diagnosed with aggressive prostate cancer
Former President Biden diagnosed with aggressive prostate cancer WASHINGTON — Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to…
-
STAT+: Novavax wins narrowed approval for its Covid-19 shot after delay
STAT+: Novavax wins narrowed approval for its Covid-19 shot after delay The Food and Drug Administration has finally approved Novavax’s Covid-19 vaccine, but in doing so has placed restrictions on it that its two competitors in the U.S. market do not face. The long-awaited license limits use of the vaccine to people 65 and older…
-
STAT+: Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies
STAT+: Vinay Prasad tapped to run FDA center that regulates vaccines, gene therapies WASHINGTON — Vinay Prasad, an academic and fierce critic of the medical mainstream, will be the next director of the Food and Drug Administration center that oversees the regulation of vaccines, gene therapies, and the blood supply. Prasad, previously an epidemiology professor at…
-
STAT+: Trump proposes billions in cuts to federal health agencies from NIH to CDC
STAT+: Trump proposes billions in cuts to federal health agencies from NIH to CDC WASHINGTON — President Trump on Friday proposed massive cuts to the federal government’s health agencies in his 2026 budget request, arguing that Congress should reduce spending by tens of billions from current levels. The request would be a 26% cut to…
-
STAT+: Justice Department sues Medicare Advantage insurers and brokers, alleging kickbacks
STAT+: Justice Department sues Medicare Advantage insurers and brokers, alleging kickbacks The Department of Justice has sued three of the largest Medicare Advantage insurers and three dominant insurance brokerages, alleging a scheme in which the health insurers bribed the brokers to steer older adults into their policies. The lawsuit targets CVS Health’s Aetna, Elevance Health’s…
-
STAT+: Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research
STAT+: Collins and fellow GOP senators speak out in opposition to Trump’s cuts to biomedical research WASHINGTON — There was broad bipartisan support at a Senate hearing Wednesday to reverse course on the Trump administration’s cuts to federally funded biomedical research. Sen. Susan Collins (Maine), the Republican chair of the Senate Appropriations Committee, kicked off…
-
STAT+: NIH said to have halted awarding of new grants to top universities
STAT+: NIH said to have halted awarding of new grants to top universities Embattled universities whose funding from the National Institutes of Health has been frozen may face further financial strain as the agency holds off awarding new grants to at least half a dozen of them, according to an email obtained by STAT. The…
-
RFK Jr. plans changes to vaccine injury reporting system
RFK Jr. plans changes to vaccine injury reporting system WASHINGTON — Health secretary Robert F. Kennedy Jr. said Tuesday that he plans to roll out changes to the vaccine injury monitoring system that would automate and increase data collection as well as look for negative impacts of the shots. Reforming the current Vaccine Adverse Event…
-
STAT+: Trump administration launches probe into pharmaceutical imports
STAT+: Trump administration launches probe into pharmaceutical imports The Trump administration disclosed it formally opened an investigation into the extent to which the importation of certain pharmaceuticals may threaten national security, a move that is a widely anticipated prelude to imposing tariffs on a potentially large number of medicines. In a Federal Register notice published…
-
STAT+: Trump gives major lift to 2026 Medicare Advantage payments
STAT+: Trump gives major lift to 2026 Medicare Advantage payments Health insurers that sell Medicare Advantage plans are going to get about $30 billion more in taxpayer money next year. President Trump’s Medicare agency finalized a rule Monday that would raise benchmark payment rates to privatized Medicare plans by 5.1% for 2026. That was higher…
-
‘Most effective way’ to prevent measles is vaccination, RFK Jr. says, in most direct remarks yet
‘Most effective way’ to prevent measles is vaccination, RFK Jr. says, in most direct remarks yet WASHINGTON — Health secretary Robert F. Kennedy Jr. said Sunday that “the most effective way to prevent the spread of measles is the MMR vaccine,” his most direct statement yet on the issue, following the death of a second child…
-
STAT+: Trump administration declines to expand Medicare coverage for obesity drugs
STAT+: Trump administration declines to expand Medicare coverage for obesity drugs The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed Medicare to cover blockbuster weight loss drugs. The rule would have brought in tens of billions of dollars in new sales for drugs like Novo…
-
STAT+: Makary’s first speech to FDA staff focuses on challenging norms, fighting chronic disease
STAT+: Makary’s first speech to FDA staff focuses on challenging norms, fighting chronic disease WASHINGTON — Marty Makary’s first address to staff as FDA commissioner on Wednesday afternoon sounded a bit like an introduction to one of his books. It included sweeping declarations about the need to challenge scientific norms, and to identify the root…
-
STAT+: Texas judge strikes down FDA’s plan to regulate lab-developed tests
STAT+: Texas judge strikes down FDA’s plan to regulate lab-developed tests WASHINGTON — A federal judge in Texas squashed the Food and Drug Administration’s plan to regulate lab-developed tests on Monday, ruling in favor of lab trade groups that said the agency was overstepping its bounds. “The Court VACATES and SETS ASIDE, in its entirety,…